A Science and Technology Blog
“Both Covishield vaccinated sera and convalescent sera were found to offer protection against the double mutant variant (B.1.617),” says Dr. Rakesh Mishra, Director of CCMB. “This is only a preliminary…
The first serosurvey was carried out in August-September 2020 and the six-month follow-up was carried out in end-January to February 2021. Widespread asymptomatic infection by mid-September when the daily cases…
Even as recently as March 6, March 4, March 3, March 2 and March 1 the Health Ministry mischievously implicated Kerala for the surge in cases when it included Kerala…
While the low sensitivity of rapid antigen tests arises from not isolating the viral RNA from the swab samples and amplification of the DNA before detection, the two indigenously developed tests follow these two vital steps, the reason why the sensitivity and specificity are far superior than that of the rapid antigen tests.
IGIB researchers have been able to detect novel coronavirus using mass spectrometer. The detection is based on the presence of two unique peptides of the virus. Sensitivity is 95% and…
Results of a randomised, control trial using hydroxychloroquine drug in 150 COVID-19 patients show that the drug does not reduce the viral load even on day 28. However, patients who…
With CSIR labs now permitted to test samples of novel coronavirus, Hyderabad-based CCMB and Delhi-based IGIB have started sequencing the genome. CCMB has already sequenced the genome of five isolates.…
An independent committee formed by CSIR in early June 2019 to investigate into image duplication and/or manipulation in published papers has submitted its report to CSIR Director-General Dr. Shekhar Mande.…
